摘要
非酒精性脂肪性肝炎(NASH)是非酒精性脂肪肝疾病的一个形成过程,主要特征为炎症、肝实质细胞损伤和纤维发生。在NASH患者中总死亡率和肝相关死亡率都在上升。考虑到非酒精性脂肪性肝疾病是西方最流行的肝功能,理解其导致NASH的机制和肝硬化的过程对这些患者的治疗是非常重要。此外,对该情况更详细地认知有助于鉴定那些容易患进展性肝病的受试者。新出的数据显示NASH的发生来源于脂肪组织、胃肠道和肝脏的同时发生过程。本文我们强调了一些近期在NASH病理机制的报道以及肝硬化的纤维化过程,为了鉴定疾病发生过程中的生物标记物或者治疗中可能的靶点。
关键词: 非酒精性脂肪性肝炎;非酒精性脂肪性肝病;纤维化
Current Molecular Medicine
Title:Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis
Volume: 16 Issue: 8
Author(s): A. Gentilini, A. Caligiuri, A. Provenzano, F. Marra
Affiliation:
关键词: 非酒精性脂肪性肝炎;非酒精性脂肪性肝病;纤维化
摘要: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease, characterized by inflammation, hepatocyte injury and fibrogenesis. Overall mortality, and liver-related mortality, are both increased in NASH patients. Considering that nonalcoholic fatty liver disease is the most prevalent hepatic abnormality in the Western world, understanding the mechanisms leading to NASH and its progression to cirrhosis is critical for a better management of these patients. Moreover, a more detailed knowledge of this condition may be helpful to identify those subjects which are more susceptible to develop progressive liver disease. Emerging data indicate that NASH progression results from parallel events originating from the liver as well as from the adipose tissue, and the gastrointestinal tract. In this review we highlight some of the most recent findings reported on the pathogenesis of NASH and its fibrogenic progression to cirrhosis, in an effort to identify possible targets for treatment or biomarkers of disease progression.
Export Options
About this article
Cite this article as:
A. Gentilini, A. Caligiuri, A. Provenzano, F. Marra , Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis, Current Molecular Medicine 2016; 16 (8) . https://dx.doi.org/10.2174/1566524016666161021163252
DOI https://dx.doi.org/10.2174/1566524016666161021163252 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiac Tumors: Clinical Perspective and Therapeutic Considerations
Current Drug Targets Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches
Current Pharmaceutical Design Gender And Susceptibility To Sepsis Following Trauma
Endocrine, Metabolic & Immune Disorders - Drug Targets Fatty Acids - Induced Lipotoxicity and Inflammation
Current Drug Metabolism Role of Chymase in Preeclampsia
Current Vascular Pharmacology Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
Current Nanomedicine Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets An Up-date of Olive Oil Phenols in Inflammation and Cancer: Molecular Mechanisms and Clinical Implications
Current Medicinal Chemistry Lipid-lowering Drug Therapy in Elderly Patients
Current Pharmaceutical Design Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Conditional Cardiac Overexpression of S100A6 Attenuates Myocyte Hypertrophy and Apoptosis Following Myocardial Infarction
Current Pharmaceutical Design Statins: Are They All the Same?
Current Drug Therapy Lower Serum Indirect Bilirubin Levels are Inversely Related to Carotid Intima-Media Thickness Progression
Current Neurovascular Research Effect of Extracts and Components of Black Tea on the Activity of β- Glucuronidase, Lipase,α-Amylase,α-Glucosidase: An in vitro Study
Current Nutrition & Food Science Vitamin D Deficiency: Universal Risk Factor for Multifactorial Diseases?
Current Drug Targets Effect of Immunoglobulin Therapy on Blood Viscosity and potential concerns of Thromboembolism, Especially in Patients with Acute Kawasaki Disease
Recent Patents on Cardiovascular Drug Discovery Genetic Aspects of Lone Atrial Fibrillation: What Do We Know?
Current Pharmaceutical Design Plant Polyphenols and Oral Health: Old Phytochemicals for New Fields
Current Medicinal Chemistry Cathinone Neurotoxicity (“The “3Ms”)
Current Neuropharmacology Editorial [Hot Topic:Metabolic Therapy: An Important Therapeutic Option for the Treatment of Cardiovascular Diseases (Executive Editors: G.M.C. Rosano and G. Barbaro)]
Current Pharmaceutical Design